These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 28760618

  • 1. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
    Weckel A, Marx M, Esteve-Fraysse MJ.
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
    [Abstract] [Full Text] [Related]

  • 2. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
    Lee SY, Kim YS, Jeong B, Carandang M, Koo JW, Oh SH, Lee JH.
    Am J Otolaryngol; 2021 Feb; 42(6):103086. PubMed ID: 34098455
    [Abstract] [Full Text] [Related]

  • 3. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
    Öztürk K, Ata N.
    Am J Otolaryngol; 2019 Feb; 40(5):711-714. PubMed ID: 31262549
    [Abstract] [Full Text] [Related]

  • 4. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
    Martin Sanz E, Zschaeck C, Gonzalez M, Mato T, Rodrigañez L, Barona R, Sanz R.
    Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
    [Abstract] [Full Text] [Related]

  • 5. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere's Disease Patients.
    Atrache Al Attrache N, Krstulovic C, Pérez Guillen V, Morera Pérez C, Pérez Garrigues H.
    J Int Adv Otol; 2016 Apr; 12(1):92-7. PubMed ID: 27340991
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB.
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.